Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 AUD | +2.86% | -23.40% | +227.27% |
04-30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
04-18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+227.27% | 8.3M | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.38% | 239B | |
+7.97% | 204B | |
-7.65% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Begins Good Laboratory Practice Preclinical Study for Brain Injury Drug Candidate